CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
CELGENE CORPORATION |
AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALTIES LIMITED, AUROLIFE PHARMA LLC and AUROBINDO PHARMA LIMITED |
2:2019cv00143 |
January 4, 2019 |
US District Court for the District of New Jersey |
Michael A Hammer |
Esther Salas |
Patent - Abbreviated New Drug Application(ANDA) |
15 U.S.C. § 1126 |
None |
Docket Report
This docket was last retrieved on February 7, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
***Civil Case Terminated. (sm) |
Filing 14 STIPULATION AND ORDER TO CONSOLIDATE; that C.A. 17-3387 is consolidated with C.A. 17-3159, C.A. 18-14111, C.A. 18-14366, C.A. 18-14715, C.A. 18-16035, C.A. 18-16395, C.A., and 19-143. The C.A. 17-3387 action shall be the lead case, and all filings shall be made only in the C.A. 17-3387; etc. Signed by Magistrate Judge Michael A. Hammer on 1/31/2019. (sm) |
Filing 13 Application and Proposed Order for Clerk's Order to extend time to answer as to Celgene's time to answer, move, or otherwise reply to the Answer, Defenses, and Counterclaims of Defendants Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, and Eugia Pharma Specialties Limited.. (LIZZA, CHARLES) |
Filing 12 Letter from Defendants on behalf of all parties to Magistrate Judge Hammer enclosing proposed Consolidation and Amended Scheduling Order. (Attachments: #1 Text of Proposed Order)(HALPERN, JAKOB) |
Filing 11 Corporate Disclosure Statement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC, EUGIA PHARMA SPECIALTIES LIMITED. (WALIA, GURPREET) |
Filing 10 ANSWER to Complaint , COUNTERCLAIM against CELGENE CORPORATION by AUROLIFE PHARMA LLC, AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LIMITED, EUGIA PHARMA SPECIALTIES LIMITED.(WALIA, GURPREET) |
Filing 9 NOTICE of Appearance by JOSEPH SCHRAMM, III on behalf of AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC, EUGIA PHARMA SPECIALTIES LIMITED (SCHRAMM, JOSEPH) |
Filing 8 NOTICE of Appearance by GURPREET SINGH WALIA on behalf of AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC, EUGIA PHARMA SPECIALTIES LIMITED (WALIA, GURPREET) |
Filing 7 NOTICE of Appearance by DAVID LEIGH MOSES on behalf of CELGENE CORPORATION (MOSES, DAVID) |
Filing 6 NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of CELGENE CORPORATION (SULLIVAN, SARAH) |
Filing 5 NOTICE of Appearance by WILLIAM C. BATON on behalf of CELGENE CORPORATION (BATON, WILLIAM) |
Filing 4 SUMMONS ISSUED as to AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC, EUGIA PHARMA SPECIALTIES LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (JB, ) |
Filing 3 AO120 Patent/Trademark Form filed. (Attachments: #1 Complaint) (sm) |
Judge Esther Salas and Magistrate Judge Michael A. Hammer added. (eu, ) |
Filing 2 Corporate Disclosure Statement by CELGENE CORPORATION. (LIZZA, CHARLES) |
Filing 1 COMPLAINT against AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC, EUGIA PHARMA SPECIALTIES LIMITED ( Filing and Admin fee $ 400 receipt number 0312-9283740), filed by CELGENE CORPORATION. (Attachments: #1 Civil Cover Sheet)(LIZZA, CHARLES) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.